Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCLZiju Y. Xu-Monette, Ken H. Young, Min Xiao et al.|Cancer Immunology Research|2019Cited by 181
Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCLZijun Y. Xu‐Monette, Ken H. Young, John D. Shaughnessy et al.|Clinical Cancer Research|2023Cited by 19
Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphomaHua You, Ken H. Young, Zijun Y. Xu‐Monette et al.|OncoImmunology|2021Cited by 12
Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosisXue Kong, Ken H. Young, Zijun Y. Xu‐Monette et al.|Blood Advances|2025Cited by 2
DNA mismatch repair defect and intratumor heterogeneous deficiency differently impact immune responses in diffuse large B-cell lymphomaZijun Y. Xu‐Monette, Ken H. Young, Cancan Luo et al.|OncoImmunology|2024Cited by 2